Department of Biotechnology, Catholic Hospitals Bochum, 44791 Bochum, Germany
Opinion
Pemafibrate Therapy is recommended for Patients at High Risk of Cardiovascular Events
Author(s): Dong Zhao*
DOI:
10.37421/2952-8127.2024.8.169
Research and Reports in Medical Sciences received 13 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 